MLA
Dasgupta, Nabarun, et al. Differential Misclassification of Overdose Safety In a Prominent Comparative Effectiveness Rct Comparing Buprenorphine and Naltrexone for Opioid Dependence. 2022. https://doi.org/10.17615/p7t5-8124
APA
Dasgupta, N., Ajazi, E., Schwartz, T., & Marshall, S. (2022). Differential misclassification of overdose safety in a prominent comparative effectiveness RCT comparing buprenorphine and naltrexone for opioid dependence. https://doi.org/10.17615/p7t5-8124
Chicago
Dasgupta, Nabarun, Elizabeth Ajazi, Todd Schwartz, and Stephen Marshall. 2022. Differential Misclassification of Overdose Safety In a Prominent Comparative Effectiveness Rct Comparing Buprenorphine and Naltrexone for Opioid Dependence. https://doi.org/10.17615/p7t5-8124